Psoriasis Injection Cleared For Limited Use To Treat COVID P
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
India's drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis for "restricted emergency use" to treat COVID-19 patients with moderate to severe acute respiratory distress, officials told PTI on Friday (10 July).

Considering the unmet medical needs to treat COVID-19, DCGI, Dr V G Somani, approved monoclonal antibody injection Itolizumab, an already approved drug of Biocon, for restricted emergency use for the treatment of "cytokine'' release syndrome in moderate to severe acute respiratory distress syndrome patients due to COVID-19, they said.

"The approval was given after its clinical trials on COVID-19 patients in India was found satisfactory by the expert committee comprising pulmonologists, pharmacologists and medical experts from AIIMS, among others, for treatment of cytokine release syndrome," an official told PTI.

Written informed consent of each patient is required before the use of this drug, he said.

Source: https://www.ndtv.com/india-news/coronavirus-treatment-skin-disease-psoriasis-injection-itolizumab-cleared-for-limited-use-to-treat-covid-patients-drug-controller-2260844
Dr. T●●●●z H●●●●●●i and 5 others like this6 shares
Like
Comment
Share
Dr. S●●●●●m S●●●●y P●●●●●l
Dr. S●●●●●m S●●●●y P●●●●●l General Medicine
This concept of written informed consemt has always baffled me. Is the patient supposed to know more than the Doctors which drug should be given and whch should be not?
Jul 11, 2020Like2
H●●●l S●●h
H●●●l S●●h General Medicine
It is the Patients "Right to Know" what treatment are they receiving .
Jul 11, 2020Like